.
LINKS
https://www.linkedin.com/in/leah-simke-04272221
https://www.scripps.edu/baran/html/group_former.html
https://www.facebook.com/leah.simke
– (1 year 6 months)La Jolla, California
– (3 years 9 months)
– (4 months)
/////////////
Leah Simke
Research Associate at Stemcentrx, Inc.
https://www.linkedin.com/in/leah-simke-04272221
https://www.scripps.edu/baran/html/group_former.html
https://www.facebook.com/leah.simke
Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from target discovery in our laboratory to treating patients in clinical trials at an accelerated pace. We are investigating many of the largest and most lethal cancers through our proprietary platforms that identify cancer stem cells, discover novel targets, engineer and manufacture antibodies and antibody drug conjugates.
Our mission is to develop therapies that cure and significantly improve survival for cancer patients. We are pioneering new approaches to eliminate cancer stem cells, which initiate and perpetuate tumors. Stemcentrx has assembled a talented and motivated team committed to this mission. We are recruiting people with world-class expertise in their practice, versatility, high energy and an entrepreneurial spirit.
Our state-of-the-art laboratories and manufacturing facilities are located in South San Francisco, California. We have a driven, ambitious, focused, hard-working, apolitical, fun, and collaborative culture that is more typical of Silicon Valley startups than large pharmaceutical companies. Our employees are compensated with salary, benefits and stock options.
Specialties
Solid Tumor Cancer Stem Cell Discovery & Targeted Therapeutics
Experience
Graduate Student, Baran Laboratory
The Scripps Research Institute
Undergraduate Researcher (Matzger Lab)
University of Michigan
Matzger Laboratory
Medicinal Chemistry Intern
Janssen, Pharmaceutical Companies of Johnson and Johnson
Neuroscience Group
Publications
Total Synthesis of Verruculogen and Fumitremorgin A Enabled by Ligand-Controlled C–H Borylation
Journal of the American Chemical Society
August 9, 2015C-H Functionalization Logic Enables Synthesis of (+)-Hongoquercin A and Related Compounds
Angewandte Chemie International Edition
June 5, 2013High Power Explosive with Good Sensitivity: A 2:1 Cocrystal of CL-20:HMX
Crystal Growth & Design
August 7, 2012
http://www.economist.com/node/21562898
http://pubs.acs.org/doi/abs/10.1021/cen-09037-notw8
http://pubs.acs.org/doi/abs/10.1021/cen-09037-notw8
Education
/////////////
No comments:
Post a Comment